Details for Patent: 9,701,709
✉ Email this page to a colleague
Which drugs does patent 9,701,709 protect, and when does it expire?
Patent 9,701,709 protects SKYCLARYS and is included in one NDA.
This patent has fifty-six patent family members in thirty-five countries.
Summary for Patent: 9,701,709
| Title: | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof |
| Abstract: | The present invention relates generally to the compound: |
| Inventor(s): | Anderson Eric, Liu Xiaofeng, Decker Andrea |
| Assignee: | REATA PHARMACEUTICALS, INC. |
| Application Number: | US14625829 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 9,701,709
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reata Pharms | SKYCLARYS | omaveloxolone | CAPSULE;ORAL | 216718-001 | Feb 28, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,701,709
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 092823 | ⤷ Try a Trial | |||
| Argentina | 124675 | ⤷ Try a Trial | |||
| Australia | 2013251602 | ⤷ Try a Trial | |||
| Brazil | 112014026640 | ⤷ Try a Trial | |||
| Canada | 2869783 | ⤷ Try a Trial | |||
| Chile | 2014002886 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
